These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7343561)

  • 1. A mathematical model of drug absorption.
    Goodacre BC; Murray PJ
    J Clin Hosp Pharm; 1981 Jun; 6(2):117-33. PubMed ID: 7343561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.
    Hurst S; Loi CM; Brodfuehrer J; El-Kattan A
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):469-89. PubMed ID: 17696800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug absorption and bioavailability problems of tablets and capsules].
    Cascioli D; Petrangeli B
    Boll Chim Farm; 1978 Aug; 117(8):437-51. PubMed ID: 743388
    [No Abstract]   [Full Text] [Related]  

  • 4. Physicochemical model for dose-dependent drug absorption.
    Dressman JB; Fleisher D; Amidon GL
    J Pharm Sci; 1984 Sep; 73(9):1274-9. PubMed ID: 6548523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations.
    Corrigan OI
    Adv Exp Med Biol; 1997; 423():111-28. PubMed ID: 9269487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting oral absorption and bioavailability.
    van de Waterbeemd H; Jones BC
    Prog Med Chem; 2003; 41():1-59. PubMed ID: 12774690
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
    Blanchard J
    Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
    [No Abstract]   [Full Text] [Related]  

  • 10. The road map to oral bioavailability: an industrial perspective.
    Thomas VH; Bhattachar S; Hitchingham L; Zocharski P; Naath M; Surendran N; Stoner CL; El-Kattan A
    Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):591-608. PubMed ID: 16859407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polar molecular surface properties predict the intestinal absorption of drugs in humans.
    Palm K; Stenberg P; Luthman K; Artursson P
    Pharm Res; 1997 May; 14(5):568-71. PubMed ID: 9165525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug absorption in the gut.
    Orme M
    Br J Anaesth; 1984 Jan; 56(1):59-67. PubMed ID: 6362692
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
    Paixão P; Gouveia LF; Morais JA
    Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption classification of oral drugs based on molecular surface properties.
    Bergström CA; Strafford M; Lazorova L; Avdeef A; Luthman K; Artursson P
    J Med Chem; 2003 Feb; 46(4):558-70. PubMed ID: 12570377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting gastrointestinal absorption of drugs.
    Levine RR
    Am J Dig Dis; 1970 Feb; 15(2):171-88. PubMed ID: 4905589
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive approaches to increase absorption of compounds during lead optimisation.
    Valko K; Butler J; Eddershaw P
    Expert Opin Drug Discov; 2013 Oct; 8(10):1225-38. PubMed ID: 23865945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives.
    Buckley ST; Fischer SM; Fricker G; Brandl M
    Eur J Pharm Sci; 2012 Feb; 45(3):235-50. PubMed ID: 22178532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.
    Darwich AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A
    J Pharm Pharmacol; 2012 Jul; 64(7):1008-24. PubMed ID: 22686346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical chemistry of supersaturated solutions and implications for oral absorption.
    Taylor LS; Zhang GGZ
    Adv Drug Deliv Rev; 2016 Jun; 101():122-142. PubMed ID: 27013254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.